AURAAura Biosciences Inc
$6.21
$0.09
(1.47%)
EarningsAug 13
Mkt Cap$632.73M
Vol816,602.00
Fundamentals
Mkt Cap
$632.73M
Volume
-
52W High
$9.54
52W Low
$4.73
PE Ratio
-3.52
Avg. Volume
860,217.84
EPS (Annual)
-$1.76
Rev/Employee
$0.00
Earnings
Aug 13
Aura Biosciences (NASDAQ:AURA) Sees Large Volume Increase - Here's What Happened
Aura Biosciences (NASDAQ:AURA) Sees Unusually-High Trading Volume - Here's What Happened...
MarketBeat
Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
US stock futures lower, Dow futures down 200 points. Norwegian Cruise Line shares fall after Q1 results, cuts FY guidance. Other stocks also down.read more...
Benzinga
HC Wainwright Has Negative Forecast for AURA FY2030 Earnings
Aura Biosciences, Inc. (NASDAQ:AURA - Free Report) - Equities research analysts at HC Wainwright decreased their FY2030 earnings per share estimates for Aura Biosciences in a note issued to investors on Wednesday, April 29th. HC Wainwright analyst A. Maldonado now forecasts that the company will ear...
MarketBeat
Levin Capital Strategies L.P. Sells 591,688 Shares of Aura Biosciences, Inc. $AURA
Levin Capital Strategies L.P. trimmed its stake in Aura Biosciences, Inc. (NASDAQ:AURA - Free Report) by 36.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,035,586 shares of the company's stock after sel...
MarketBeat
Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Update
Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) was the recipient of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totaling 2,013,075 shares, a decrease of 23.0% from the March 31st total of 2,615,841 shares. Currently, 3.3% of...
MarketBeat
Are Medical Stocks Lagging Aura Biosciences (AURA) This Year?
Here is how Aura Biosciences, Inc. (AURA) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.
Zacks
Does Aura Biosciences (AURA) Have the Potential to Rally 179.84% as Wall Street Analysts Expect?
The consensus price target hints at a 179.8% upside potential for Aura Biosciences (AURA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks
Aura Biosciences (NASDAQ:AURA) Insider Sells $82,400.76 in Stock
Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) insider Conor Kilroy sold 11,738 shares of the business's stock in a transaction that occurred on Thursday, April 16th. The shares were sold at an average price of $7.02, for a total value of $82,400.76. Following the sale, the insider owned...
MarketBeat
Conor Kilroy Sells 11,738 Shares of Aura Biosciences (NASDAQ:AURA) Stock
Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) insider Conor Kilroy sold 11,738 shares of the business's stock in a transaction on Thursday, April 16th. The shares were sold at an average...
MarketBeat
Aura Biosciences, Inc. (AURA) Just Flashed Golden Cross Signal: Do You Buy?
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
Zacks
<
1
2
...
>